Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | USP2 | O75604 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | MMP9 | P14780 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Piposulfan SCHEMBL28095073 | 0.96 | ALDH1A1 (0.41) | ALDH1A1KDM4EUSP2LMNAHPGD | |
| Piposulfan SCHEMBL18281513 | 0.93 | GNAI3 (0.40) | ALDH1A1KDM4EUSP2LMNAHPGD | |
| Piposulfan SCHEMBL27866406 | 0.91 | ALDH1A1 (0.60) | ALDH1A1KDM4EUSP2LMNAHPGD | |
| Piposulfan SCHEMBL14874457 | 0.87 | ALDH1A1 (0.41) | ALDH1A1KDM4EUSP2LMNAHPGD | |
| SCHEMBL7036057 | 0.80 | ATM (0.55) | ALDH1A1KDM4EUSP2LMNAHPGD | |
| SCHEMBL11884245 | 0.77 | ALDH1A1 (0.41) | ALDH1A1KDM4EUSP2LMNAHPGD | |
| SCHEMBL12789680 | 0.73 | TDP1 (0.44) | ALDH1A1HPGDTDP1HSD17B10ALOX15 | |
| SCHEMBL7554603 | 0.72 | ALDH1A1 (0.59) | ALDH1A1KDM4EUSP2LMNAMEN1 | |
| SCHEMBL2069595 | 0.72 | LMNA (0.52) | ALDH1A1KDM4EUSP2LMNATSHR | |
| SCHEMBL10862611 | 0.71 | HPGD (0.46) | ALDH1A1HPGDMEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 35786 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4748859-A2 | CHEMICALLY AND PHOTOCHEMICALLY INITIATED CELL MEMBRANE BLEBBING TO INDUCE CELL VESICLE PRODUCTION, MODIFICATIONS THEREOF, AND USES THEREOF | The Regents of the University of California (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4743490-A1 | HUMANIZED ANTI-CD7 ANTIBODY | Christian-Albrechts-Universität zu Kiel (DE) | 2026-05-20 | — | — | EP | claimed |
| WO-2026099502-A1 | NOVEL DRUG CONJUGATES FOR TESTING CELLULAR DRUG UPTAKE | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2026-05-15 | — | — | WO | claimed |
| US-20260116861-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-04-30 | — | — | US | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| EP-3515892-B1 | COMPOUNDS AND METHODS FOR IDO AND TDO MODULATION, AND INDICATIONS THEREFOR | PLEXXIKON INC (US) | 2026-04-15 | — | — | EP | claimed |
| US-20260085100-A1 | METHODS OF ANTIGEN PRODUCTION | THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY (US) | 2026-03-26 | — | — | US | claimed |
| US-12576124-B2 | Formulation of a conjugate of a tubulysin analog to a cell-binding molecule | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2026-03-17 | — | — | US | claimed |
| EP-4698185-A1 | METHODS AND SYSTEMS FOR IMPROVING ANTI-CANCER THERAPIES | Osasuna Therapeutics SA (CH) | 2026-02-25 | — | — | EP | claimed |
| EP-4694909-A1 | METHODS OF MODULATING THE EPITHELIAL-MESENCHYMAL TRANSITION | RS Oncology, LLC (US) | 2026-02-18 | — | — | EP | claimed |
| WO-1999042578-A2 | MODULATION OF CELL PROLIFERATION, METHODS AND REAGENTS | COLD SPRING HARBOR LABORATORY (US) | 1999-08-26 | — | — | WO | claimed |
| US-5916596-A | WATER INSOLUBLE DRUGS AND DRUG DELIVERY | VIVORX PHARMACEUTICALS, INC. (US) | 1999-06-29 | — | — | US | claimed |
| WO-1998014174-A1 | PROTEIN STABILIZED PHARMACOLOGICALLY ACTIVE AGENTS, METHODS FOR THE PREPARATION THEREOF AND METHODS FOR THE USE THEREOF | VIVORX PHARMACEUTICALS, INC. (US) | 1998-04-09 | — | — | WO | claimed |
| WO-1996025152-A1 | PROCESS OF PREPARING THERAPEUTIC COMPOSITIONS CONTAINING NANOPARTICLES | NANOSYSTEMS L.L.C. (US) | 1996-08-22 | — | — | WO | claimed |
| US-5510118-A | ADSORBING SURFACE MODIFIERS ONTO DRUG SUBSANCE | NANOSYSTEMS LLC (US) | 1996-04-23 | — | — | US | claimed |
| US-5494683-A | REDUCED TOXICITY, EFFICIENCY | EASTMAN KODAK COMPANY (US) | 1996-02-27 | — | — | US | claimed |
| US-5399363-A | IV administration for insoluble medicaments | EASTMAN KODAK COMPANY (US) | 1995-03-21 | — | — | US | claimed |
| EP-0577215-A1 | Surface modified anticancer nanoparticles | NanoSystems L.L.C. (US) | 1994-01-05 | — | — | EP | claimed |
| US-5145684-A | SURFACE MODIFIED DRUG NANOPARTICLES | STERLING DRUG INC. (US) | 1992-09-08 | — | — | US | claimed |
| EP-0499299-A2 | Surface modified drug nanoparticles | NanoSystems L.L.C. (US) | 1992-08-19 | — | — | EP | claimed |